295 related articles for article (PubMed ID: 8260708)
1. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.
Uchiyama H; Barut BA; Mohrbacher AF; Chauhan D; Anderson KC
Blood; 1993 Dec; 82(12):3712-20. PubMed ID: 8260708
[TBL] [Abstract][Full Text] [Related]
2. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.
Kim I; Uchiyama H; Chauhan D; Anderson KC
Br J Haematol; 1994 Jul; 87(3):483-93. PubMed ID: 7993788
[TBL] [Abstract][Full Text] [Related]
3. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B.
Chauhan D; Uchiyama H; Akbarali Y; Urashima M; Yamamoto K; Libermann TA; Anderson KC
Blood; 1996 Feb; 87(3):1104-12. PubMed ID: 8562936
[TBL] [Abstract][Full Text] [Related]
5. Characterization of adhesion molecules on human myeloma cell lines.
Uchiyama H; Barut BA; Chauhan D; Cannistra SA; Anderson KC
Blood; 1992 Nov; 80(9):2306-14. PubMed ID: 1421401
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand triggered interleukin-6 secretion in multiple myeloma.
Urashima M; Chauhan D; Uchiyama H; Freeman GJ; Anderson KC
Blood; 1995 Apr; 85(7):1903-12. PubMed ID: 7535594
[TBL] [Abstract][Full Text] [Related]
7. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
Zhang L; Chen SL; Chen WM; Liu JW
Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
[TBL] [Abstract][Full Text] [Related]
8. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
Nefedova Y; Landowski TH; Dalton WS
Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
[TBL] [Abstract][Full Text] [Related]
10. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures.
Lokhorst HM; Lamme T; de Smet M; Klein S; de Weger RA; van Oers R; Bloem AC
Blood; 1994 Oct; 84(7):2269-77. PubMed ID: 7919345
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells.
Urashima M; Ogata A; Chauhan D; Hatziyanni M; Vidriales MB; Dedera DA; Schlossman RL; Anderson KC
Blood; 1996 Mar; 87(5):1928-38. PubMed ID: 8634441
[TBL] [Abstract][Full Text] [Related]
12. Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma.
Thomas X; Anglaret B; Magaud JP; Epstein J; Archimbaud E
Leuk Lymphoma; 1998 Dec; 32(1-2):107-19. PubMed ID: 10037006
[TBL] [Abstract][Full Text] [Related]
13. Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.
Michigami T; Shimizu N; Williams PJ; Niewolna M; Dallas SL; Mundy GR; Yoneda T
Blood; 2000 Sep; 96(5):1953-60. PubMed ID: 10961900
[TBL] [Abstract][Full Text] [Related]
14. Novel therapies targeting the myeloma cell and its bone marrow microenvironment.
Hideshima T; Chauhan D; Podar K; Schlossman RL; Richardson P; Anderson KC
Semin Oncol; 2001 Dec; 28(6):607-12. PubMed ID: 11740818
[TBL] [Abstract][Full Text] [Related]
15. The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.
Hideshima T; Chauhan D; Schlossman R; Richardson P; Anderson KC
Oncogene; 2001 Jul; 20(33):4519-27. PubMed ID: 11494147
[TBL] [Abstract][Full Text] [Related]
16. Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model.
Okada T; Hawley RG; Kodaka M; Okuno H
Clin Exp Metastasis; 1999; 17(7):623-9. PubMed ID: 10845562
[TBL] [Abstract][Full Text] [Related]
17. beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells.
Gupta D; Podar K; Tai YT; Lin B; Hideshima T; Akiyama M; LeBlanc R; Catley L; Mitsiades N; Mitsiades C; Chauhan D; Munshi NC; Anderson KC
Exp Hematol; 2002 Jul; 30(7):711-20. PubMed ID: 12135668
[TBL] [Abstract][Full Text] [Related]
18. VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion.
Roldán E; García-Pardo A; Brieva JA
J Exp Med; 1992 Jun; 175(6):1739-47. PubMed ID: 1588291
[TBL] [Abstract][Full Text] [Related]
19. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
20. alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells.
Vacca A; Ria R; Presta M; Ribatti D; Iurlaro M; Merchionne F; Tanghetti E; Dammacco F
Exp Hematol; 2001 Aug; 29(8):993-1003. PubMed ID: 11495705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
